Yu‐Hua Hui

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene

Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 233 citations

Life Sciences, Oncology, Pharmacology +17

Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo

Clark A. Briggs, David J. Anderson, Jorge D. Brioni et al. · Pharmacology Biochemistry and Behavior · 1997 · 192 citations

Life Sciences, Neuroscience, Pharmacology +12

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

S. Betty Yan, Victoria L. Peek, Rose T. Ajamie et al. · Investigational New Drugs · 2012 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul et al. · Molecular Cancer Therapeutics · 2014 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs

Yu‐Hua Hui, Naijia Huang, Lewis Ebbert et al. · Journal of Pharmacological and Toxicological Methods · 2007 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +2